Statement on joint working with the CQC and HTA
04 January 2013
The Care Quality Commission (CQC), the Human Tissue Authority (HTA) and the Human Fertilisation and Embryology Authority (HFEA) have agreed principles about how they will ensure they work together effectively.
These arrangements, in the form of memoranda of understanding, will ensure the three regulators share information about the services they regulate in common, respect each organisation’s independence and continue to explore ways to develop more effective and efficient partnership working to promote quality and safety.
HFEA Chief Executive Peter Thompson said:
“Good regulation increasingly requires regulators to work together. The joint working protocol we have devised with the CQC and HTA will promote that closer working relationship, ensuring that important information is shared and avoiding duplication of our roles. I am sure this will result in a more effective regulatory service and make a real difference for licensed clinics whilst maintaining quality of care and patient safety.”
ENDS
Notes to editors
The Care Quality Commission registers those who provide and manage regulated activities in relation to health and adult social care in England, and monitor their compliance with the regulatory requirements they have to meet.
The HTA licences and inspects organisations that remove, store and use tissue for medical treatment, post-mortem examination and teaching.
The HFEA was set up in August 1991 as part of the Human Fertilisation and Embryology Act 1990. The HFEA’s principal tasks are to license and monitor clinics that carry out in vitro fertilisation (IVF), artificial insemination (AI) and human embryo research. The HFEA also regulates the storage of gametes (eggs and sperm) and embryos. See www.hfea.gov.uk for further details.
Page last updated: 15 February 2013